Le Lézard
Classified in: Science and technology, Business
Subject: PDT

Neurotechnology Releases New Version of StockGeist.ai Platform for Real-Time Monitoring of Publicly Traded Companies


VILNIUS, Lithuania, May 11, 2021 /PRNewswire/ -- Neurotechnology, a developer of state-of-the-art deep learning-based solutions, today announced the release of a new version of its AI-powered StockGeist.ai platform for monitoring publicly traded companies in real-time. This release includes a newly developed REST API for developers who wish to harness the full power of StockGeist's data and integrate it into their own projects. It also includes a number of dashboard performance upgrades and delivers continuous updates to the list of stocks covered by StockGeist.ai, including the healthcare and technology sectors as well as the S&P 500 list. Users can now register their accounts and set up personal profiles, and the newly introduced scheme of user tiers supports flexible pricing tailored to everyone's needs.

"With StockGeist.ai, you can quickly feel the spirit of the most recent developments in the business world."

StockGeist is a web-based platform that uses deep learning models to provide a convenient, real-time monitor of the sentiment and context behind developments in the stock market as reflected in the media and social media. StockGeist.ai's intuitive interface lets users quickly build customized watchlists with companies of interest to observe the dynamics in their rankings and track other up-to-date information.

"With StockGeist.ai, you can quickly feel the spirit of the most recent developments in the business world," said Dr. Vytautas Abramavicius, StockGeist.ai team lead from Neurotechnology. "Our web platform aggregates a tremendous amount of data from various media and social media sources. Using modern deep learning-based NLP (Natural Language Processing) models, StockGeist.ai allows users to derive meaningful insights from noisy data. It reflects our best efforts to bring this information to investors and traders in an intuitive and efficient way, so they can make faster decisions regarding stocks of interest," Abramavicius added.

StockGeist.ai was first released as a free-to-use platform on October 7, 2020. Since then, a number of new features have been added:

For more information about StockGeist.ai, please visit: www.stockgeist.ai.

About Neurotechnology
Neurotechnology is a developer of high-precision algorithms and software based on deep neural networks and other AI-related technologies. The company was launched in 1990 in Vilnius, Lithuania, with the key idea of using neural networks for various applications, such as biometric person identification, computer vision, robotics and artificial intelligence. Since the first release of its fingerprint identification system in 1991, the company has delivered more than 200 products and version upgrades. More than 3,000 system integrators, security companies and hardware providers in more than 140 countries integrate Neurotechnology's algorithms into their products. The company's algorithms have achieved top results in independent technology evaluations, including NIST MINEX, PFT, FRVT, IREX and FVC-onGoing.

SOURCE Neurotechnology


These press releases may also interest you

at 22:10
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: